# Sono-Tek Q2 2027 EPS Miss

> Sono-Tek's Q2 2027 earnings miss reveals medical growth surge amid operational challenges.
- Title: Sono-Tek Q2 2027 EPS Miss | Shortify
- Summary: Sono-Tek's Q2 2027 earnings miss reveals medical growth surge amid operational challenges. Sono-Tek's Q2 2027 EPS fell to $0.02, 50% below estimates, as…
- Keywords: sono-tek, q2 2027, eps, medical revenue, revenue miss, operational leverage, segment breakdown, 2027, Miss, Alphastreet - Earnings Decoded. Market Intelligence Delivered
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/sono-tek-q2-2027-deep-dive-whats-behind-the-50-0-miss
- Author: AlphaStreet Newsdesk
- Published: 2026-10-14T19:35:11+00:00
- Read time: 1 min
- Topics: sono-tek, q2 2027, eps, medical revenue, revenue miss, operational leverage, segment breakdown
## Sono-Tek Q2 2027 Earnings
Sono-Tek Corporation delivered a disappointing miss in Q2 2027 with GAAP EPS of $0.02 falling 50% short of the $0.04 consensus estimate.
## Revenue Growth vs Earnings
The company reported a modest 1% year-over-year revenue increase to $5.2M despite a 50% EPS miss.
## Medical Segment Surge
Medical revenue surged 209% to $3.1M, representing 59% of total quarterly revenue.
## Legacy Segment Decline
Electronics/Microelectronics declined 17% to $1.2M while Multi-Axis Coating Systems fell 3% to $2.0M.
## Margin Divergence
Net margin improved to 7% from 8.1% a year ago while net income declined 14% to $366,000.
## Backlog Conversion
The $9.5M equipment and service backlog provides revenue visibility but raises questions about conversion efficiency.
## What to Watch
Monitor medical revenue sustainability and whether the 209% growth rate represents a one-time inflection or sustained expansion.
## Key takeaway

Sono-Tek's Q2 2027 EPS fell to $0.02, 50% below estimates, as medical revenue surged 209% to $3.1M while legacy segments declined.